These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

474 related articles for article (PubMed ID: 19142023)

  • 1. Arteriovenous fistula patency associated with angiotensin-converting enzyme I/D polymorphism and ACE inhibition or AT1 receptor blockade.
    Moon JY; Jeong KH; Paik SS; Han JJ; Lee SH; Lee TW; Ihm CG; Kim MJ; Chung JH
    Nephron Clin Pract; 2009; 111(2):c110-6. PubMed ID: 19142023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is AV fistula patency associated with angiotensin-converting enzyme (ACE) polymorphism and ACE inhibitor intake?
    Heine GH; Ulrich C; Köhler H; Girndt M
    Am J Nephrol; 2004; 24(4):461-8. PubMed ID: 15331890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of ACE inhibitor therapy to prevent dialysis in nondiabetic nephropathy: influence of the ACE insertion/deletion polymorphism.
    Vegter S; Perna A; Hiddema W; Ruggenenti P; Remuzzi G; Navis G; Postma MJ
    Pharmacogenet Genomics; 2009 Sep; 19(9):695-703. PubMed ID: 19696696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of angiotensin-converting enzyme gene polymorphism on the progression of immunoglobulin A nephropathy in Malaysian patients.
    Draman CR; Kong NC; Gafor AH; Rahman AF; Zainuddin S; Mustaffa WM; Radzi AM; Shamsul AS
    Singapore Med J; 2008 Nov; 49(11):924-9. PubMed ID: 19037561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gene polymorphism of angiotensin-converting enzyme and angiotensin II type 1 receptor in patients with congestive heart failure.
    Pop D; Zdrenghea D; Procociuc LM; Popal A
    Rom J Intern Med; 2007; 45(4):349-54. PubMed ID: 18767410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin converting enzyme inhibitors maintain polytetrafluroethylene graft patency.
    Sajgure A; Choudhury A; Ahmed Z; Choudhury D
    Nephrol Dial Transplant; 2007 May; 22(5):1390-8. PubMed ID: 17267534
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of ace gene polymorphism in the development of angioedema secondary to angiotensin converting enzyme inhibitors and angiotensin II receptor blockers.
    Gulec M; Caliskaner Z; Tunca Y; Ozturk S; Bozoglu E; Gul D; Erel F; Kartal O; Karaayvaz M
    Allergol Immunopathol (Madr); 2008; 36(3):134-40. PubMed ID: 18680700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM; Holubkov R; Postava L; Janosko K; MacGowan GA; Mathier M; Murali S; Feldman AM; London B
    J Am Coll Cardiol; 2004 Nov; 44(10):2019-26. PubMed ID: 15542286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of angiotensin converting enzyme insertion/deletion polymorphism on long-term total graft occlusion after coronary artery bypass surgery.
    Dayi SU; Tartan Z; Terzi S; Kasikcioglu H; Uyarel H; Orhan G; Alper AT; Ciloglu F; Cam N
    Heart Surg Forum; 2005; 8(5):E373-7. PubMed ID: 16146835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of pneumonia risk by an angiotensin I-converting enzyme inhibitor in elderly Japanese inpatients according to insertion/deletion polymorphism of the angiotensin I-converting enzyme gene.
    Takahashi T; Morimoto S; Okaishi K; Kanda T; Nakahashi T; Okuro M; Murai H; Nishimura Y; Iwai K; Matsumoto M
    Am J Hypertens; 2005 Oct; 18(10):1353-9. PubMed ID: 16202861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The angiotensin-converting enzyme insertion/deletion polymorphism and serum levels of angiotensin-converting enzyme in venous thromboembolism. Data from a case control study.
    Ay C; Bencur P; Vormittag R; Sailer T; Jungbauer C; Vukovich T; Mannhalter C; Pabinger I
    Thromb Haemost; 2007 Oct; 98(4):777-82. PubMed ID: 17938801
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of RAS inhibitors associated with ACE gene polymorphisms in type 2 diabetic nephropathy.
    Seki N; Hashimoto N; Suzuki Y; Yagui K; Saito Y
    Diabetes Res Clin Pract; 2006 May; 72(2):135-41. PubMed ID: 16290123
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of the polymorphism of the angiotensin-converting enzyme gene on the drug treatment in patients with chronic heart failure].
    Huang WY; Sun M; Zhou HY; Pei ZF; Yang TL
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Dec; 29(6):686-9. PubMed ID: 16114558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiotensin converting enzyme insertion/deletion polymorphism and short-term renal response to ACE inhibition: role of sodium status.
    van der Kleij FG; Schmidt A; Navis GJ; Haas M; Yilmaz N; de Jong PE; Mayer G; de Zeeuw D
    Kidney Int Suppl; 1997 Dec; 63():S23-6. PubMed ID: 9407415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Angiotensin converting enzyme gene polymorphism and type 2 diabetic nephropathy].
    Liao L; Lei MX; Chen HL
    Hunan Yi Ke Da Xue Xue Bao; 2003 Dec; 28(6):553-6. PubMed ID: 15804059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin-1 and vasopressin plasma levels are not associated with the insertion/deletion polymorphism of the human angiotensin I-converting enzyme gene in patients with coronary artery disease.
    Al-Fakhri N; Linhart RE; Philipp M; Heidt M; Hehrlein FW; Gardemann A; Katz N
    J Hum Hypertens; 2003 Feb; 17(2):133-8. PubMed ID: 12574792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Demonstrating the pharmacogenetic effects of angiotensin-converting enzyme inhibitors on long-term prognosis of diastolic heart failure.
    Wu CK; Luo JL; Tsai CT; Huang YT; Cheng CL; Lee JK; Lin LY; Lin JW; Hwang JJ; Chiang FT
    Pharmacogenomics J; 2010 Feb; 10(1):46-53. PubMed ID: 19752885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic polymorphism, medical therapy and sequential cardiac function in patients with heart failure.
    Cuoco MA; Pereira AC; Mota Gde F; Krieger JE; Mansur AJ
    Arq Bras Cardiol; 2008 Apr; 90(4):252-6. PubMed ID: 18516385
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of insertion/deletion polymorphism of the angiotensin-converting enzyme gene with angio-oedema accompanying chronic urticaria but not chronic urticaria without angio-oedema or the autologous serum skin test response.
    Akcali C; Ozkur M; Erbagci Z; Benlier N; Aynacioglu AS
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):83-6. PubMed ID: 18181977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of angiotensin-converting enzyme gene polymorphism on neurohormonal responses to high- versus low-dose enalapril in advanced heart failure.
    Tang WH; Vagelos RH; Yee YG; Fowler MB
    Am Heart J; 2004 Nov; 148(5):889-94. PubMed ID: 15523323
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.